150 related articles for article (PubMed ID: 35754502)
1. Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis.
Chen X; Wang S; Zhang L; Yuan S; Xu T; Zhu F; Zhang Y; Jia L
Front Pharmacol; 2022; 13():873166. PubMed ID: 35754502
[TBL] [Abstract][Full Text] [Related]
2. Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis.
Zhang Y; Wang S; Chen Y; Zhang J; Yang J; Xian J; Li L; Zhao H; Hoffman RM; Zhang Y; Jia L
Front Oncol; 2021; 11():666549. PubMed ID: 34195076
[TBL] [Abstract][Full Text] [Related]
3. Daurisoline Inhibits ESCC by Inducing G1 Cell Cycle Arrest and Activating ER Stress to Trigger Noxa-Dependent Intrinsic and CHOP-DR5-Dependent Extrinsic Apoptosis via p-eIF2
Yuan S; Pan Y; Xu T; Zhang L; Chen X; Wang F; Liu Q; Jia L
Oxid Med Cell Longev; 2022; 2022():5382263. PubMed ID: 35965681
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis.
Zhang L; Li L; Chen X; Yuan S; Xu T; Zhao W; Li M; Wang F; Hoffman RM; Jia L
Phytomedicine; 2023 Jan; 108():154493. PubMed ID: 36265256
[TBL] [Abstract][Full Text] [Related]
5. Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4-CHOP-DR5 Axis in Human Esophageal Cancer Cells.
Chen P; Hu T; Liang Y; Li P; Chen X; Zhang J; Ma Y; Hao Q; Wang J; Zhang P; Zhang Y; Zhao H; Yang S; Yu J; Jeong LS; Qi H; Yang M; Hoffman RM; Dong Z; Jia L
Clin Cancer Res; 2016 Aug; 22(16):4145-57. PubMed ID: 26983464
[TBL] [Abstract][Full Text] [Related]
6. Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
Wang T; Zhang P; Chen L; Qi H; Chen H; Zhu Y; Zhang L; Zhong M; Shi X; Li Q
J Pharmacol Exp Ther; 2022 Jan; 380(1):15-25. PubMed ID: 34740946
[TBL] [Abstract][Full Text] [Related]
7. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest and apoptosis induction by
Li CY; Lee SC; Lai WL; Chang KF; Huang XF; Hung PY; Lee CP; Hsieh MC; Tsai NM
Food Sci Nutr; 2021 Feb; 9(2):1088-1098. PubMed ID: 33598192
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma.
Sha B; Chen X; Wu H; Li M; Shi J; Wang L; Liu X; Chen P; Hu T; Li P
Apoptosis; 2019 Oct; 24(9-10):826-836. PubMed ID: 31342239
[TBL] [Abstract][Full Text] [Related]
10. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study.
Li HY; Zhang J; Sun LL; Li BH; Gao HL; Xie T; Zhang N; Ye ZM
Cell Death Dis; 2015 Jan; 6(1):e1604. PubMed ID: 25611379
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed exerts anticancer effects by inducing G
Li X; Song H; Kong F; Guo Y; Chen Y; Zhang L; Gao D; Zhao X; Zhang H
Oncol Lett; 2019 Feb; 17(2):1851-1858. PubMed ID: 30675247
[TBL] [Abstract][Full Text] [Related]
12. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L
PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316
[TBL] [Abstract][Full Text] [Related]
13. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xian J; Wang S; Jiang Y; Li L; Cai L; Chen P; Liu Y; Zeng X; Chen G; Ding C; Hoffman RM; Jia L; Zhao H; Zhang Y
Cancer Biol Med; 2021 Mar; 19(4):504-17. PubMed ID: 33733647
[TBL] [Abstract][Full Text] [Related]
15. Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo.
Lv J; Lin S; Peng P; Cai C; Deng J; Wang M; Li X; Lin R; Lin Y; Fang A; Li Q
Onco Targets Ther; 2017; 10():1261-1267. PubMed ID: 28280360
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Seki N; Toh U; Sayers TJ; Fujii T; Miyagi M; Akagi Y; Kusukawa J; Kage M; Shirouzu K; Yamana H
Mol Cancer Ther; 2010 Jun; 9(6):1842-51. PubMed ID: 20515944
[TBL] [Abstract][Full Text] [Related]
17. Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells.
Zhu H; Yang W; He LJ; Ding WJ; Zheng L; Liao SD; Huang P; Lu W; He QJ; Yang B
PLoS One; 2012; 7(12):e52333. PubMed ID: 23284992
[TBL] [Abstract][Full Text] [Related]
18. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway.
Lin FZ; Wang SC; Hsi YT; Lo YS; Lin CC; Chuang YC; Lin SH; Hsieh MJ; Chen MK
Phytomedicine; 2019 Feb; 54():1-8. PubMed ID: 30668359
[TBL] [Abstract][Full Text] [Related]
19. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis.
Xiao S; Liu N; Yang X; Ji G; Li M
Free Radic Biol Med; 2021 Feb; 164():58-75. PubMed ID: 33307164
[TBL] [Abstract][Full Text] [Related]
20. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
